Results 141 to 150 of about 84,459 (353)

Validation of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis [PDF]

open access: bronze, 2017
L.E. Burgers   +6 more
openalex   +1 more source

Temporomandibular disorders and neck disability in individuals with cervical disc herniation

open access: yesEuropean Journal of Oral Sciences, EarlyView.
Abstract The primary aim of this study was to investigate the prevalence and severity of temporomandibular disorders (TMDs), and temporomandibular joint (TMJ) pain in patients with cervical disc herniation. The secondary aim was to investigate the relationship between neck disability, neck pain, sociodemographic factors, TMD, and TMJ pain.
Turgay Altunalan   +3 more
wiley   +1 more source

The "Clinical Topics" from the Electronic Health Record of Patients with Rheumatoid Arthritis Before Initiating Targeted Therapies and Association with Future Treatment Course. [PDF]

open access: yesACR Open Rheumatol
Objective Rheumatoid arthritis (RA) is a heterogeneous disease, with patients experiencing varied disease courses and responses to treatment. The objective of this study was to apply topic modeling to RA patient electronic health record (EHR) data and determine (1) the clinical topics/subgroups in those with RA before initiation of a biologic/targeted ...
Tang J   +8 more
europepmc   +2 more sources

Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes

open access: green, 2020
Joanna Rhodes   +11 more
openalex   +2 more sources

Recurrent fever, arthralgia and asymmetric genu varum of unexpected etiology [PDF]

open access: gold, 2014
Liliana Quaresma   +3 more
openalex   +1 more source

Ankle Magnetic Resonance Imaging in Juvenile Idiopathic Arthritis Versus Non-Juvenile Idiopathic Arthritis Patients with Arthralgia [PDF]

open access: gold, 2022
Monika Ostrowska   +5 more
openalex   +1 more source

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow   +3 more
wiley   +1 more source

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy